Ursula-Friederike Habenicht

Title: Innovations in Male Contraception by Ursula-Friederike Habenicht

Introduction

Ursula-Friederike Habenicht is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of male contraception, holding a total of three patents. His work focuses on innovative formulations that aim to provide effective contraceptive solutions for men.

Latest Patents

One of his latest patents is a male contraceptive formulation comprising norethisterone. This formulation utilizes a progestin that possesses both estrogenic and androgenic properties, which is remarkably effective for spermatogenesis suppression in males. The progestin Norethisterone (NET), along with its derivatives such as Norethisterone acetate and Norethisterone enanthate, can induce oligozoospermia or azoospermia in males when administered in sufficient doses. Additionally, formulations that include an androgen, such as a testosterone derivative like testosterone undecanoate, are particularly effective as male contraceptive solutions. Another significant patent involves the use of peptides derived from zona pellucida proteins for contraception. This invention focuses on pharmaceutical formulations that contain these peptides without eliciting an immunogenic effect.

Career Highlights

Throughout his career, Ursula-Friederike Habenicht has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Bayer Schering Pharma AG. His expertise in the field has led to groundbreaking advancements in male contraceptive methods.

Collaborations

Ursula-Friederike Habenicht has collaborated with esteemed colleagues such as Eberhard Nieschlag and Axel Kamischke. Their combined efforts have contributed to the development of innovative contraceptive solutions.

Conclusion

Ursula-Friederike Habenicht's work in male contraception represents a significant advancement in reproductive health. His innovative formulations and collaborations have the potential to change the landscape of contraceptive options for men.